Niagen Bioscience (OCD1) Stock Forecast & Price Target
OCD1 Analyst Ratings
OCD1 Stock 12 Month Forecast
Average Price Target
EUR 8.92▲(395.78% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Susan Anderson | Canaccord Genuity | EUR 8.92→EUR 8.03 | buy | 346.20%Upside | Assigned | 10/30/26 | ||
| Sean McGowan | Roth MKM | EUR 8.92 | buy | 395.78%Upside | Reiterated | 10/12/26 | ||
| Ram Selvaraju | H.C. Wainwright | EUR 9.82 | buy | 445.36%Upside | Reiterated | 08/05/26 | ||
| Jeffrey Cohen | Ladenburg Thalmann & Co. | EUR 10.71→EUR 9.82 | buy | 445.36%Upside | Reiterated | 07/21/26 | ||
| Ilya Zubkov | Freedom Capital Markets | EUR 8.03 | buy | 346.20%Upside | Initiated | 07/06/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Susan Anderson | 10/30/26 | EUR 8.92→EUR 8.03 | buy | 346.20%Upside | Assigned | Canaccord Genuity | ||
| Sean McGowan | 10/12/26 | EUR 8.92 | buy | 395.78%Upside | Reiterated | Roth MKM | ||
| Ram Selvaraju | 08/05/26 | EUR 9.82 | buy | 445.36%Upside | Reiterated | H.C. Wainwright | ||
| Jeffrey Cohen | 07/21/26 | EUR 10.71→EUR 9.82 | buy | 445.36%Upside | Reiterated | Ladenburg Thalmann & Co. | ||
| Ilya Zubkov | 07/06/26 | EUR 8.03 | buy | 346.20%Upside | Initiated | Freedom Capital Markets |
Best Analysts Covering Niagen Bioscience
Copying Jeffrey Cohen's trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of -3.45% per trade.
Copying Jeffrey Cohen's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of +24.09% per trade.
Copying Jeffrey Cohen's trades and holding each position for 2 Years would result in 30.77% of your transactions generating a profit, with an average return of +33.39% per trade.
OCD1 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 12 | 10 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 10 | 12 | 10 | 5 |
In the current month, OCD1 has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OCD1 average Analyst price target in the past 3 months is 8.92.
OCD1 Financial Forecast
OCD1 Earnings Forecast
Next quarter’s earnings estimate for OCD1 is EUR 0.00 with a range of -EUR 0.03 to EUR 0.02. The previous quarter’s EPS was EUR 0.01. Its overall industry beat the EPS estimate 38.89% of the time in the past 12 months.
OCD1 Sales Forecast
Next quarter’s sales forecast for OCD1 is EUR 28.94M with a range of EUR 24.44M to EUR 30.98M. The previous quarter’s sales results were EUR 26.67M. Its overall industry beat sales estimates 57.45% of the time in the past 12 months.
